VALUE OF INFORMATION (VOI) ANALYSIS FOR RESEARCH DECISIONS EMERGING GOOD PRACTICES TASK FORCE- FINAL RECOMMENDATIONS
Author(s)
Anirban Basu, PhD, University of Washington, Seattle, USA; Rachael Fleurence, PhD, Medical Device Innovation Consortium (MDIC), Arlington, USA; James F. Murray, PhD, Eli Lilly and Company, Carmel, USA; Gillian D Sanders Schmidler, PhD, Duke University, Washington, USA; Lotte Steuten, PhD, MSc, Fred Hutchinson Cancer Research Center, Seattle, USA
Presentation Documents
Value of Information (VOI) methods provide essential tools to quantify the value of additional evidence to reduce uncertainty in decision making and inform research prioritization decisions. In this session, members of the task force will 1) provide an overview of VOI and the types of decisions where it can be used, 2) present the good practice recommendations from the task force papers. This will be followed by a panel discussion, incorporating a range of perspectives, on how VOI can be integrated in practice, highlighting possible barriers and potential solutions and detailing the implications for decision-making of incorporating VOI methods.
This interactive forum will be informative for anyone involved in supporting and making research decisions including researchers, HTA agencies, decision makers, and industry analysts. Come along and join in the debate!
Conference/Value in Health Info
2018-05, ISPOR 2018, Baltimore, MD, USA
Code
F6
Topic
Economic Evaluation, Methodological & Statistical Research